Details for New Drug Application (NDA): 071202
✉ Email this page to a colleague
NDA 071202 describes SENSORCAINE, which is a drug marketed by Fresenius Kabi Usa and is included in eight NDAs. It is available from four suppliers. Additional details are available on the SENSORCAINE profile page.
The generic ingredient in SENSORCAINE is bupivacaine hydrochloride. There are twelve drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride profile page.
The generic ingredient in SENSORCAINE is bupivacaine hydrochloride. There are twelve drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride profile page.
Summary for 071202
| Tradename: | SENSORCAINE |
| Applicant: | Fresenius Kabi Usa |
| Ingredient: | bupivacaine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;SPINAL | Strength | 0.75% | ||||
| Approval Date: | Apr 15, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
